NASDAQ:MEDS - MultiCell Technologies Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding MultiCell Technologies Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $6.05 -0.44 (-6.78 %) (As of 03/27/2020 04:00 PM ET) Add Compare Today's Range$5.75Now: $6.05▼$6.1750-Day Range N/A52-Week Range$2.10Now: $6.05▼$11.60Volume69,942 shsAverage Volume191,836 shsMarket Capitalization$39.57 millionP/E RatioN/ADividend YieldN/ABeta1.68 ProfileAdvanced ChartEarningsInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Trxade Group, Inc. owns and operates a business-to-business Web-based marketplace focused on the pharmaceutical industry in the United States. It operates through Trxade, Inc.; Community Specialty Pharmacy, LLC; and Other segments. The company operates a Web based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com, a Web-based pharmaceutical marketplace; InventoryRx.com, a Web-based pharmaceutical exchange platform; Pharmabayonline that provides proprietary pharmaceutical data analytics and governmental reimbursement benchmarks analysis to the United States-based independent pharmacies and pharmaceutical databases; and RxGuru, a desktop application, which provides product information. The company also operates a retail specialty pharmacy. In addition, it operates Delivmeds.com, a consumer-based app to provide delivery of pharmaceutical products; and Trxademso.com to assist independent retail pharmacies on pricing, distribution, and logistics. Trxade Group, Inc. is based in Land O'Lakes, Florida.Read More Industry, Sector and Symbol Stock Exchange NASDAQ Industry Drugs, proprietaries, & sundries Sub-IndustryN/A SectorRetail/Wholesale Current SymbolNASDAQ:MEDS Previous Symbol CUSIPN/A CIKN/A Webhttp://www.trxade.com/ Phone800-261-0281Debt Debt-to-Equity Ratio0.26 Current Ratio4.51 Quick Ratio4.45Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$3.83 million Price / Sales10.33 Cash Flow$0.00 per share Price / Cash Flow3,816.57 Book Value$0.16 per share Price / Book37.81Profitability EPS (Most Recent Fiscal Year)N/A Net Income$10,000.00 Net Margins0.33% Return on Equity1.26% Return on Assets0.61%Miscellaneous Employees31 Outstanding Shares6,540,000Market Cap$39.57 million Next Earnings Date3/31/2020 (Estimated) OptionableNot Optionable Receive MEDS News and Ratings via Email Sign-up to receive the latest news and ratings for MEDS and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:MEDS Rates by TradingView MultiCell Technologies (NASDAQ:MEDS) Frequently Asked Questions How has MultiCell Technologies' stock been impacted by COVID-19 (Coronavirus)? MultiCell Technologies' stock was trading at $4.96 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MEDS shares have increased by 22.0% and is now trading at $6.05. View which stocks have been mosted impacted by Coronavirus. When is MultiCell Technologies' next earnings date? MultiCell Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, March 31st 2020. View our earnings forecast for MultiCell Technologies. Has MultiCell Technologies been receiving favorable news coverage? Media headlines about MEDS stock have trended somewhat positive this week, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. MultiCell Technologies earned a news impact score of 0.8 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future. View the latest news aboutMultiCell Technologies. Who are some of MultiCell Technologies' key competitors? Some companies that are related to MultiCell Technologies include McKesson (MCK), AmerisourceBergen (ABC), Cardinal Health (CAH), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), Trxade Group (TRXD) and biOasis Technologies (BIOAF). What other stocks do shareholders of MultiCell Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other MultiCell Technologies investors own include Inovio Pharmaceuticals (INO), Allied Healthcare Products (AHPI), Francesca's (FRAN), Gilead Sciences (GILD), Alphabet (GOOG), Heat Biologics (HTBX), Micron Technology (MU), Ollie's Bargain Outlet (OLLI), Opko Health (OPK) and Roku (ROKU). Who are MultiCell Technologies' key executives? MultiCell Technologies' management team includes the following people: Mr. Surendra K. Ajjarapu, Founder, Chairman, CEO, Treasurer & Sec. (Age 49)Mr. Prashant Patel, Founder, Pres, COO & Director (Age 46)Mr. Howard A. Doss, Chief Financial Officer (Age 66)Dr. Ramesh Kenchappa M.S.(Pharma), Ph.D., Chief Scientific OfficerMr. Steven D. Lee Esq., Gen. Counsel What is MultiCell Technologies' stock symbol? MultiCell Technologies trades on the NASDAQ under the ticker symbol "MEDS." When did MultiCell Technologies' quiet period expire? MultiCell Technologies' quiet period expired on Tuesday, March 24th. MultiCell Technologies had issued 806,452 shares in its initial public offering on February 13th. The total size of the offering was $5,241,938 based on an initial share price of $6.50. During MultiCell Technologies' quiet period, underwriters and any insiders involved in the IPO were restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company. How do I buy shares of MultiCell Technologies? Shares of MEDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is MultiCell Technologies' stock price today? One share of MEDS stock can currently be purchased for approximately $6.05. How big of a company is MultiCell Technologies? MultiCell Technologies has a market capitalization of $39.57 million and generates $3.83 million in revenue each year. MultiCell Technologies employs 31 workers across the globe. View additional information about MultiCell Technologies. What is MultiCell Technologies' official website? The official website for MultiCell Technologies is http://www.trxade.com/. How can I contact MultiCell Technologies? MultiCell Technologies' mailing address is 3840 Land O' Lakes Blvd., Land O' Lakes FL, 34639. The company can be reached via phone at 800-261-0281 or via email at [email protected] MarketBeat Community Rating for MultiCell Technologies (NASDAQ MEDS)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 4 (Vote Outperform)Underperform Votes: 4 (Vote Underperform)Total Votes: 8MarketBeat's community ratings are surveys of what our community members think about MultiCell Technologies and other stocks. Vote "Outperform" if you believe MEDS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MEDS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/28/2020 by MarketBeat.com StaffFeatured Article: What sectors are represented in the FTSE 100 index?
